Pulling SEC filings + quote and writing the call…
BEAM
Beam Therapeutics Inc.
Next earnings Aug 3, 2026 · consensus $-1.14 EPS, $15.6M rev
Last earnings -2.7% on 2026-05-07
$35.53
▲ +4.07%$35.53▲ +113.78%
over 1Y
L $16.01EODHDH $35.53
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+4.1%
1W+14.2%
1M+19.3%
3M+41.2%
YTD+30.9%
1Y+113.8%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 25 analysts
Strong Buy
Revenue grew 120.0% YoY; but unprofitable (net margin -57.2%).
Beam Therapeutics Inc. shows $140M in FY2025 revenue (+120.0% YoY), a -57.2% net margin, and -6.5% ROE.
Sources: SEC EDGAR (CIK 0001745999, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 10:23:25 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.